Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 6OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Neoplasms 2Ototoxicity 1Lung Neoplasms 1Laryngeal Neoplasms 1Laryngeal Diseases 1Hearing Loss 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Gallbladder Cancer Unresectable 1Esophageal Squamous Cell Carcinoma 1Cognitive Dysfunction 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 6Cisplatin 5Gefitinib 3Drug Therapy 3Docetaxel 3Radiotherapy 2Pemetrexed 2Paclitaxel 2Oxaliplatin 2Erlotinib Hydrochloride 2olaparib 1Watchful Waiting 1Thoracoscopy 1Thoracic Surgery, Video-Assisted 1Surgical Procedures, Operative 1Sunitinib 1Standard of Care 1Simvastatin 1Robotic Surgical Procedures 1Risk Factors 1Radiation 1Olanzapine 1Nutrition Assessment 1Neoadjuvant Therapy 1Muscle Stretching Exercises 1Irinotecan 1Indocyanine Green 1Fish Oils 1Environmental Biomarkers 1Enteral Nutrition 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Lung Neoplasms × Chemoradiotherapy × Clear all
NCT00686322 2011-09-15

Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)

Taipei Veterans General Hospital, Taiwan

Phase 4 Completed
6 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡